2012 annual financial data

Relmada Therapeutics, Inc. 2012 Net margin

Relmada Therapeutics, Inc. 2012 net margin with verified reported values.

Direct answer

Net margin was -151.77%.

Operating income was -12,052 USD and net income was -12,052 USD.
Operating cash flow was -7,565 USD.
Alpha Vantage

Get free Relmada Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,941 USD
Operating income
-12,052 USD
Net income
-12,052 USD
Operating cash flow
-7,565 USD

Explore related company data

View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Relmada Therapeutics, Inc. financial years